Clonal Spread and Pathoadaptive Changes of Community-Associated Methicillin-Resistant Staphylococcus aureus in Egypt - Report - MDSpire

Clonal Spread and Pathoadaptive Changes of Community-Associated Methicillin-Resistant Staphylococcus aureus in Egypt

  • By

  • Nehal A. Saif

  • Reem A. Elghaish

  • Eman Badr

  • Shaimaa F. Mouftah

  • Sherine M. Shawky

  • Ben Pascoe

  • Samuel K. Sheppard

  • Mohamed Elhadidy

  • April 2, 2026

  • 0 min

Share

Clonal Spread and Pathoadaptive Changes of CA-MRSA in Egypt

Overview

This study analyzed 123 community-associated MRSA isolates from Alexandria, Egypt, revealing diverse clonal lineages with significant antimicrobial resistance and virulence factors. Genomic and phenotypic data highlight the adaptation and persistence of CA-MRSA strains in the community setting.

Background

Antimicrobial resistance poses a critical global health threat, with Egypt experiencing high rates driven by unregulated antibiotic use and limited stewardship. MRSA, particularly community-associated strains (CA-MRSA), have expanded beyond healthcare settings, carrying distinct genetic elements such as SCCmec types IV or V and virulence factors like PVL. Understanding the population structure and adaptive mechanisms of CA-MRSA is essential for controlling its spread and impact in North Africa.

Data Highlights

Sample SourceNumber of Isolates
Aspirate44
Wound20
Pus26
Abscess8
Mini-bronchoalveolar lavage4
Blood3
Sputum3
Catheters3
Peritoneal fluid1

Key Findings

  • 123 non-duplicate CA-MRSA isolates were collected from diverse clinical specimens in Alexandria, Egypt.
  • Isolates were confirmed as S. aureus by phenotypic and molecular methods, including nuc gene detection.
  • Methicillin resistance was confirmed phenotypically and genotypically via cefoxitin resistance and mecA gene presence.
  • CA-MRSA classification followed CDC epidemiological criteria, emphasizing community onset and lack of prior healthcare exposure.
  • Antimicrobial susceptibility testing covered multiple antibiotic classes, revealing resistance profiles relevant to local treatment challenges.
  • Genomic analysis aimed to elucidate population structure, resistome, virulome, and evolutionary dynamics of CA-MRSA in North Africa.

Clinical Implications

The identification of diverse CA-MRSA clones with distinct resistance and virulence profiles underscores the need for targeted antimicrobial stewardship and infection control strategies in community settings. Enhanced surveillance integrating genomic data can inform empirical therapy and help mitigate the spread of resistant strains in Egypt and similar regions.

Conclusion

This genomic snapshot of CA-MRSA in Egypt reveals complex clonal diversity and adaptive traits facilitating persistence in the community, highlighting the importance of integrated approaches to monitor and control MRSA dissemination.

References

  1. WHO/2021 -- Global priority pathogens list for antibiotic resistance
  2. CDC/2019 -- Community-associated MRSA epidemiological criteria
  3. CLSI/2020 -- Performance standards for antimicrobial susceptibility testing

Original Source(s)

Related Content